Germany
Japan
United Kingdom
China
AAV2 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV Control Particles
View as table DownloadAAV2 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAVDJ with CMV promoter-driven expression of P53-GFP, >10^13 GC/mL, 100ul
AAVDJ with CMV promoter-driven expression of P53-GFP, >10^13 GC/mL, 50ul
AAV8 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV8 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV6 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV6 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV9 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV9 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV7 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV7 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV1 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV1 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAVrh.10 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAVrh.10 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV5 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV5 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul
AAV-PHP.eB with CMV promoter-driven expression of GFP, >10^13 GC/mL, 100ul
AAV-PHP.eB with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50ul